Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

Affiliations

• ¹ Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: [email protected].
• ² Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA. Electronic address: [email protected].
• ³ Vaccine and Infectious Disease Division, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
• ⁴ Vaccine and Infectious Disease Division, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Departments of Laboratory Medicine and Pathology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
• ⁵ Statistical Center for HIV/AIDS Research and Prevention (SCHARP), University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
• ⁶ Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
• ⁷ Department of Surgery, Duke University Medical Center, Durham, NC, USA.
• ⁸ Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
• ⁹ Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY, USA.
• ¹⁰ Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA.
• ¹¹ Department of Pediatrics and Center for Childhood Infections and Vaccines, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.
• ¹² Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
• ¹³ Vaccine and Infectious Disease Division, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Departments of Laboratory Medicine and Pathology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.
• ¹⁴ Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA.
• ¹⁵ NYU Langone Vaccine Center and Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
• ¹⁶ Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
• ¹⁷ NYU Langone Hospital-Long Island Vaccine Center Research Clinic and Division of Infectious Disease, Department of Medicine, NYU Long Island School of Medicine, Mineola, NY, USA.
• ¹⁸ Department of Medicine, University of Washington, Seattle, WA, USA.
• ¹⁹ Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA; Hope Clinic of Emory Vaccine Center, Atlanta, GA, USA.
• ²⁰ Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, WA, USA; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
• ²¹ FHI360, Durham, NC 27701, USA.
• ²² Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
• ²³ Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
• ²⁴ Emory Vaccine Center, Yerkes National Primate Research Center, Department of Pediatrics, Department of Microbiology and Immunology, Emory School of Medicine, Emory University, Atlanta, GA, USA.
• ²⁵ Department of Surgery, Duke University Medical Center, Durham, NC, USA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA. Electronic address: [email protected].